Literature DB >> 33492478

Preliminary study of AI-assisted diagnosis using FDG-PET/CT for axillary lymph node metastasis in patients with breast cancer.

Zongyao Li1, Kazuhiro Kitajima2, Kenji Hirata3, Ren Togo4, Junki Takenaka5, Yasuo Miyoshi6, Kohsuke Kudo5,7, Takahiro Ogawa8, Miki Haseyama8.   

Abstract

BACKGROUND: To improve the diagnostic accuracy of axillary lymph node (LN) metastasis in breast cancer patients using 2-[18F]FDG-PET/CT, we constructed an artificial intelligence (AI)-assisted diagnosis system that uses deep-learning technologies.
MATERIALS AND METHODS: Two clinicians and the new AI system retrospectively analyzed and diagnosed 414 axillae of 407 patients with biopsy-proven breast cancer who had undergone 2-[18F]FDG-PET/CT before a mastectomy or breast-conserving surgery with a sentinel lymph node (LN) biopsy and/or axillary LN dissection. We designed and trained a deep 3D convolutional neural network (CNN) as the AI model. The diagnoses from the clinicians were blended with the diagnoses from the AI model to improve the diagnostic accuracy.
RESULTS: Although the AI model did not outperform the clinicians, the diagnostic accuracies of the clinicians were considerably improved by collaborating with the AI model: the two clinicians' sensitivities of 59.8% and 57.4% increased to 68.6% and 64.2%, respectively, whereas the clinicians' specificities of 99.0% and 99.5% remained unchanged.
CONCLUSIONS: It is expected that AI using deep-learning technologies will be useful in diagnosing axillary LN metastasis using 2-[18F]FDG-PET/CT. Even if the diagnostic performance of AI is not better than that of clinicians, taking AI diagnoses into consideration may positively impact the overall diagnostic accuracy.

Entities:  

Keywords:  2-[18f]FDG-PET/CT; AI-assisted diagnosis; Axillary lymph node; Breast cancer; Deep convolutional neural network

Year:  2021        PMID: 33492478     DOI: 10.1186/s13550-021-00751-4

Source DB:  PubMed          Journal:  EJNMMI Res        ISSN: 2191-219X            Impact factor:   3.138


  12 in total

1.  Twenty-five years of follow-up in patients with operable breast carcinoma: correlation between clinicopathologic factors and the risk of death in each 5-year period.

Authors:  Rodrigo Arriagada; Monique G Le; Ariane Dunant; Maurice Tubiana; Genevieve Contesso
Journal:  Cancer       Date:  2006-02-15       Impact factor: 6.860

Review 2.  The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature.

Authors:  Rebecca Peare; R T Staff; S D Heys
Journal:  Breast Cancer Res Treat       Date:  2010-02-07       Impact factor: 4.872

3.  MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis.

Authors:  X Liang; J Yu; B Wen; J Xie; Q Cai; Q Yang
Journal:  Clin Radiol       Date:  2017-01-27       Impact factor: 2.350

4.  Diagnostic and prognostic value of (18)F-FDG PET/CT for axillary lymph node staging in patients with breast cancer.

Authors:  Kazuhiro Kitajima; Kazuhito Fukushima; Yasuo Miyoshi; Takayuki Katsuura; Yoko Igarashi; Yusuke Kawanaka; Miya Mouri; Kaoru Maruyama; Toshiko Yamano; Hiroshi Doi; Koichiro Yamakado; Seiichi Hirota; Shozo Hirota
Journal:  Jpn J Radiol       Date:  2015-12-29       Impact factor: 2.374

Review 5.  FDG-PET/CT in the staging of local/regional metastases in breast cancer.

Authors:  Ian J Robertson; Fiona Hand; Malcolm R Kell
Journal:  Breast       Date:  2011-07-31       Impact factor: 4.380

Review 6.  Deep Learning in Medical Image Analysis.

Authors:  Dinggang Shen; Guorong Wu; Heung-Il Suk
Journal:  Annu Rev Biomed Eng       Date:  2017-03-09       Impact factor: 9.590

7.  Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.

Authors:  Carolin Riegger; Angela Koeninger; Verena Hartung; Friedrich Otterbach; Rainer Kimmig; Michael Forsting; Andreas Bockisch; Gerald Antoch; Till A Heusner
Journal:  Acta Radiol       Date:  2012-09-22       Impact factor: 1.990

8.  Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients.

Authors:  Till A Heusner; Sherko Kuemmel; Steffen Hahn; Angela Koeninger; Friedrich Otterbach; Monia E Hamami; Klaus R Kimmig; Michael Forsting; Andreas Bockisch; Gerald Antoch; Alexander Stahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-05       Impact factor: 9.236

9.  Comparison of machine learning methods for classifying mediastinal lymph node metastasis of non-small cell lung cancer from 18F-FDG PET/CT images.

Authors:  Hongkai Wang; Zongwei Zhou; Yingci Li; Zhonghua Chen; Peiou Lu; Wenzhi Wang; Wanyu Liu; Lijuan Yu
Journal:  EJNMMI Res       Date:  2017-01-28       Impact factor: 3.138

10.  Artificial Intelligence and Human Trust in Healthcare: Focus on Clinicians.

Authors:  Onur Asan; Alparslan Emrah Bayrak; Avishek Choudhury
Journal:  J Med Internet Res       Date:  2020-06-19       Impact factor: 5.428

View more
  3 in total

Review 1.  Artificial intelligence for nuclear medicine in oncology.

Authors:  Kenji Hirata; Hiroyuki Sugimori; Noriyuki Fujima; Takuya Toyonaga; Kohsuke Kudo
Journal:  Ann Nucl Med       Date:  2022-01-14       Impact factor: 2.668

2.  Diagnostic Performance of FDG-PET/CT Scan as Compared to US-Guided FNA in Prediction of Axillary Lymph Node Involvement in Breast Cancer Patients.

Authors:  Hazem I Assi; Ibrahim A Alameh; Jessica Khoury; Maroun Bou Zerdan; Vanessa Akiki; Maya Charafeddine; Ghida I El Saheb; Fares Sukhon; Eman Sbaity; Serine Baydoun; Nina Shabb; Ghina Berjawi; Mohamad B Haidar
Journal:  Front Oncol       Date:  2021-10-01       Impact factor: 6.244

Review 3.  Artificial Intelligence in Breast Ultrasound: The Emerging Future of Modern Medicine.

Authors:  Srushti S Mahant; Anuj R Varma
Journal:  Cureus       Date:  2022-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.